139 related articles for article (PubMed ID: 35241527)
21. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2.
González-Pacheco FR; Deudero JJ; Castellanos MC; Castilla MA; Alvarez-Arroyo MV; Yagüe S; Caramelo C
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1395-401. PubMed ID: 16899768
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of pretreatment serum levels of VEGF and its receptors, IL- 8, and their prognostic value in type I and II endometrial cancer patients.
Kotowicz B; Fuksiewicz M; Jonska-Gmyrek J; Berezowska A; Radziszewski J; Bidzinski M; Kowalska M
PLoS One; 2017; 12(10):e0184576. PubMed ID: 28991928
[TBL] [Abstract][Full Text] [Related]
24. Expression of VEGF and its receptors in the bovine endometrium throughout the estrous cycle: effects of VEGF on prostaglandin production in endometrial cells.
Tasaki Y; Nishimura R; Shibaya M; Lee HY; Acosta TJ; Okuda K
J Reprod Dev; 2010 Apr; 56(2):223-9. PubMed ID: 20035107
[TBL] [Abstract][Full Text] [Related]
25. Novel noncanonical regulation of soluble VEGF/VEGFR2 signaling by mechanosensitive ion channel TRPV4.
Kanugula AK; Adapala RK; Midha P; Cappelli HC; Meszaros JG; Paruchuri S; Chilian WM; Thodeti CK
FASEB J; 2019 Jan; 33(1):195-203. PubMed ID: 29957061
[TBL] [Abstract][Full Text] [Related]
26. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
[TBL] [Abstract][Full Text] [Related]
27. Loss of osteoglycin promotes angiogenesis in limb ischaemia mouse models via modulation of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 signalling pathway.
Wu QH; Ma Y; Ruan CC; Yang Y; Liu XH; Ge Q; Kong LR; Zhang JW; Yan C; Gao PJ
Cardiovasc Res; 2017 Jan; 113(1):70-80. PubMed ID: 28069703
[TBL] [Abstract][Full Text] [Related]
28. Protein Phosphotyrosine Phosphatase 1B (PTP1B) in Calpain-dependent Feedback Regulation of Vascular Endothelial Growth Factor Receptor (VEGFR2) in Endothelial Cells: IMPLICATIONS IN VEGF-DEPENDENT ANGIOGENESIS AND DIABETIC WOUND HEALING.
Zhang Y; Li Q; Youn JY; Cai H
J Biol Chem; 2017 Jan; 292(2):407-416. PubMed ID: 27872190
[TBL] [Abstract][Full Text] [Related]
29. HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.
Halle MK; Tangen IL; Berg HF; Hoivik EA; Mauland KK; Kusonmano K; Berg A; Hurtado A; Kalland KH; Øyan AM; Stefansson I; Vintermyr OK; Werner HM; Haldorsen IS; Trovik J; Salvesen HB; Krakstad C
Br J Cancer; 2018 Feb; 118(3):378-387. PubMed ID: 29169184
[TBL] [Abstract][Full Text] [Related]
30. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth.
Kuo LJ; Hung CS; Chen WY; Chang YJ; Wei PL
J Surg Res; 2013 Nov; 185(1):264-72. PubMed ID: 23759331
[TBL] [Abstract][Full Text] [Related]
31. FGD5 Regulates VEGF Receptor-2 Coupling to PI3 Kinase and Receptor Recycling.
Farhan MA; Azad AK; Touret N; Murray AG
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2301-2310. PubMed ID: 29051140
[TBL] [Abstract][Full Text] [Related]
32. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
33. ERK signaling is required for VEGF-A/VEGFR2-induced differentiation of porcine adipose-derived mesenchymal stem cells into endothelial cells.
Almalki SG; Agrawal DK
Stem Cell Res Ther; 2017 May; 8(1):113. PubMed ID: 28499402
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor receptor 2 as a marker for malignant vascular tumors and mesothelioma: an immunohistochemical study of 262 vascular endothelial and 1640 nonvascular tumors.
Miettinen M; Rikala MS; Rys J; Lasota J; Wang ZF
Am J Surg Pathol; 2012 Apr; 36(4):629-39. PubMed ID: 22314185
[TBL] [Abstract][Full Text] [Related]
35. HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer.
Konecny GE; Santos L; Winterhoff B; Hatmal M; Keeney GL; Mariani A; Jones M; Neuper C; Thomas B; Muderspach L; Riehle D; Wang HJ; Dowdy S; Podratz KC; Press MF
Br J Cancer; 2009 Jan; 100(1):89-95. PubMed ID: 19088718
[TBL] [Abstract][Full Text] [Related]
36. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2.
Zhang Z; Neiva KG; Lingen MW; Ellis LM; Nör JE
Cell Death Differ; 2010 Mar; 17(3):499-512. PubMed ID: 19834490
[TBL] [Abstract][Full Text] [Related]
37. Role of protein tyrosine phosphatase 1B in vascular endothelial growth factor signaling and cell-cell adhesions in endothelial cells.
Nakamura Y; Patrushev N; Inomata H; Mehta D; Urao N; Kim HW; Razvi M; Kini V; Mahadev K; Goldstein BJ; McKinney R; Fukai T; Ushio-Fukai M
Circ Res; 2008 May; 102(10):1182-91. PubMed ID: 18451337
[TBL] [Abstract][Full Text] [Related]
38. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
39. EGFR expression and HER2/neu overexpression/amplification in endometrial carcinosarcoma.
Livasy CA; Reading FC; Moore DT; Boggess JF; Lininger RA
Gynecol Oncol; 2006 Jan; 100(1):101-6. PubMed ID: 16157366
[TBL] [Abstract][Full Text] [Related]
40. Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis.
Johansson I; Aaltonen KE; Ebbesson A; Grabau D; Wigerup C; Hedenfalk I; Rydén L
Genes Chromosomes Cancer; 2012 Apr; 51(4):375-83. PubMed ID: 22170730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
